GlassScriptPhysician profile
Abbas A Shehadeh
NPI 1215900774
$28,259.40
in general payments reported to CMS, 2019-2025
48 companies · $4,639 in 2025
The $4,639 reported for 2025 was more than what 91% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,565 · 2020: $1,751 · 2021: $1,564 · 2022: $2,164 · 2023: $3,475 · 2024: $10K · 2025: $4,639.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $11K · Travel and Lodging: $7,504 · Education: $52.49.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $10,660.29 |
| Travel and Lodging | $7,503.68 |
| Education | $52.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $6,601.88 | 2021-2025 | Onyx Frontier, Symplicity G3, Corevalve Evolut R |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $4,562.22 | 2019-2025 | Lifevest |
| Abbott Laboratories | $3,832.58 | 2019-2025 | Perclose Proglide, Perclose Prostyle, Mitraclip |
| Cvrx, INC. | $2,913.31 | 2022-2025 | Barostim Neo System |
| Novartis Pharmaceuticals Corporation | $1,136.85 | 2019-2025 | |
| Amgen INC. | $915.73 | 2019-2025 | Repatha, Repatha |
| Astrazeneca Pharmaceuticals LP | $867.06 | 2019-2025 | Farxiga, Fasenra |
| Novo Nordisk INC | $763.41 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Lumenis Be INC | $624.71 | 2024 | M22 |
| Boston Scientific Corporation | $623.63 | 2019-2025 | Watchman Flx, Cds - Mct/Cem Monitoring, Avvigo Guidance System |
| Merck Sharp & Dohme LLC | $565.95 | 2020-2025 | Verquvo, Lagevrio, Steglatro |
| Medtronic Vascular, INC. | $540.16 | 2019-2020 | |
| Edwards Lifesciences Corporation | $488.20 | 2022-2025 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Boehringer Ingelheim Pharmaceuticals, INC. | $434.16 | 2021-2025 | Jardiance |
| Bayer Healthcare Pharmaceuticals INC. | $378.36 | 2024-2025 |
Show all 45 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $289.79 | 2019-2023 | Xarelto |
| E.R. Squibb & Sons, L.L.C. | $286.16 | 2021-2025 | Eliquis, Camzyos |
| Biotronik INC. | $284.08 | 2019-2021 | |
| Lexicon Pharmaceuticals, INC. | $246.93 | 2023-2024 | Inpefa |
| Cardinal Health 200 LLC | $190.24 | 2019-2020 | |
| Atricure, INC. | $185.20 | 2019-2023 | |
| Heartflow, INC. | $166.61 | 2024-2025 | |
| Pfizer INC. | $161.97 | 2019-2025 | |
| Sanofi-Aventis U.S. LLC | $146.58 | 2019 | |
| Amarin Pharma, INC. | $145.13 | 2019-2022 | |
| Regeneron Healthcare Solutions, INC. | $129.97 | 2019-2022 | |
| Glaxosmithkline, LLC. | $100.85 | 2019-2025 | Arexvy, Shingrix |
| Philips North America LLC | $91.99 | 2020-2022 | |
| Baxter Healthcare | $80.99 | 2023-2025 | Hillrom - Cardiac Ambulatory Monitor, Hillrom - Carnation Ambulatory Monitor |
| Abiomed | $67.07 | 2025 | |
| Cardiovascular Systems INC. | $61.35 | 2020-2022 | |
| Esperion Therapeutics, INC. | $55.41 | 2021-2024 | Nexletol |
| Bridgebio Pharma, INC. | $50.78 | 2025 | Attruby |
| Exact Sciences Corporation | $41.67 | 2025 | Cologuard Collection Kit |
| Alnylam Pharmaceuticals INC. | $34.86 | 2025 | Onpattro |
| Acist Medical Systems, INC. | $30.07 | 2023 | |
| Actelion Pharmaceuticals US, INC. | $28.56 | 2019 | |
| Dexcom, INC. | $27.00 | 2021 | |
| Scpharmaceuticals INC. | $19.11 | 2023 | |
| Angiodynamics, INC. | $18.96 | 2023 | Angiovac |
| Lundbeck LLC | $17.06 | 2024 | Rexulti |
| Nestle Healthcare Nutrition INC. | $15.00 | 2021 | |
| Kiniksa Pharmaceuticals International, Plc | $14.03 | 2024 | Arcalyst |
| Shockwave Medical, INC | $13.30 | 2023 | Shockwave Intravascular Lithotripsy (Ivl) System With The Shockwave C2+ Coronary |
| Zoll Circulation INC | $10.47 | 2022 |
3 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Abbas Shehadeh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.